ConductScience.org, home

Paper32632160

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment.

GeurtsvanKessel CH and 15 others. Nat Commun, 2020. Cited by 292 papers, by iCite.

Cite this record

ConductScience Library. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Papers, record 32632160. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32632160

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment.
PubMed
Journal
Nat Commun
PubMed
Year
2020
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
292
iCite
Relative citation ratio, by iCite
12.2
iCite
Revised in PubMed
2021-07-06
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1GeurtsvanKessel CHCorine Hhttps://orcid.org/0000-0002-7678-314X
2Okba NMANisreen M Ahttps://orcid.org/0000-0002-2394-1079
3Igloi ZZsofiahttps://orcid.org/0000-0001-7537-6334
4Bogers SSusanne
5Embregts CWECarmen W Ehttps://orcid.org/0000-0003-4710-9225
6Laksono BMBrigitta M
7Leijten LLonneke
8Rokx CCasper
9Rijnders BBart
10Rahamat-Langendoen JJanette
11van den Akker JPCJohannes P C
12van Kampen JJAJeroen J A
13van der Eijk AAAnnemiek A
14van Binnendijk RSRob S
15Haagmans BBarthttps://orcid.org/0000-0001-6221-2015
16Koopmans MMarionhttps://orcid.org/0000-0002-5204-2312

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Coronavirus InfectionsMajor topic
Pneumonia, ViralMajor topic
Serologic TestsMajor topic
Antibodies, Neutralizing
Betacoronavirus
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Enzyme-Linked Immunosorbent Assay
High-Throughput Screening Assays
Humans
Luminescent Measurements
Neutralization Tests
Pandemics
SARS-CoV-2
Sensitivity and Specificity

Source PubMed

Download CSV of topics

Cited by242

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 292 citations.

PMIDTitleJournalYearIn PapersSource
42163160SARS-CoV-2 seroprevalence among pregnant women during the first three waves of the COVID-19 pandemic in southern Mozambique.BMC Pregnancy Childbirth2026https://conductscience.org/library/papers/42163160PubMed
41947067Optimising COVID-19 episode identification using serology and PCR/rapid antigen testing: insights from the BRACE trial.BMC Infect Dis2026https://conductscience.org/library/papers/41947067PubMed
41787546Estimating the incidence of SARS-CoV-2 infections by jointly modelling seroprevalence, hospitalization and mortality data, February 2020 - January 2021, Belgium.Arch Public Health2026https://conductscience.org/library/papers/41787546PubMed
41668864Molecular and seroepidemiology of SARS-CoV-2 among influenza-like illness and severe Acute respiratory illness cases in selected health facilities in Ethiopia.Front Public Health2025https://conductscience.org/library/papers/41668864PubMed
41315372Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern France.Sci Rep2025https://conductscience.org/library/papers/41315372PubMed
40454936Comparison of NADAL COVID IgG/IgM rapid test and DiaSorin Liaison SARS-CoV-2 S1/S2 IgG assay across different blood sources and substrates.Microbiol Spectr2025https://conductscience.org/library/papers/40454936PubMed
40303713The Luciferase Immunoprecipitation System (LIPS) Targeting the Spike Protein of SARS-CoV-2 Is More Accurate than Nucleoprotein-Based LIPS and ELISAs for Mink Serology.Transbound Emerg Dis2023https://conductscience.org/library/papers/40303713PubMed
40284930Evaluation of SARS-CoV-2 Seroprevalence and Variant Distribution During the Delta-Omicron Transmission Waves in Greater Accra, Ghana, 2021.Viruses2025https://conductscience.org/library/papers/40284930PubMed
40263514Comparative evaluation of in-house ELISA and two commercial serological assays for the detection of antibodies against SARS-CoV-2.Sci Rep2025https://conductscience.org/library/papers/40263514PubMed
40196112A bivalent mRNA vaccine against RSV infection in rodent models.Front Immunol2025https://conductscience.org/library/papers/40196112PubMed
39844374SARS-CoV-2 infection and vaccination status in six ethnic groups in Amsterdam, The Netherlands, May to November 2022.Epidemiol Infect2025https://conductscience.org/library/papers/39844374PubMed
39730470Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico.Sci Rep2024https://conductscience.org/library/papers/39730470PubMed
39570844Serological survey in a university community after the fourth wave of COVID-19 in Senegal.PLoS One2024https://conductscience.org/library/papers/39570844PubMed
39378229Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study.PLoS One2024https://conductscience.org/library/papers/39378229PubMed
39063546Anti-SARS-CoV-2 Neutralizing Responses in Various Populations: Use of a Rapid Surrogate Lateral Flow Assay and Correlations with Anti-RBD Antibody Levels.Life (Basel)2024https://conductscience.org/library/papers/39063546PubMed
38664455Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model.Sci Rep2024https://conductscience.org/library/papers/38664455PubMed
38620937Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort.Clin Immunol Commun2021https://conductscience.org/library/papers/38620937PubMed
38427100Quantification of SARS-CoV-2 monoclonal IgG mass fraction by isotope dilution mass spectrometry.Anal Bioanal Chem2024https://conductscience.org/library/papers/38427100PubMed
38228735Multicentric evaluation of sensitivity of eight commercial anti-SARS-CoV-2 antibody assays and their correlation to virus neutralization titers in seropositive subjects.Sci Rep2024https://conductscience.org/library/papers/38228735PubMed
38107343Comparative analysis of SARS-CoV-2 detection methods using stool, blood, and nasopharyngeal swab samples.Pan Afr Med J2023https://conductscience.org/library/papers/38107343PubMed

See all 242 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
PRNT149830PubTator's text mininghttps://conductscience.org/library/genes/149830NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32632160

GET https://conductscience.org/api/papers/v1/32632160/cited_by?page=2